Portland Investment Counsel Inc. Portfolio Holdings

Portland Investment Counsel Inc.

  • $230 Million
  • Q3 2025

Portland Investment Counsel Inc. has filed its 13F form on November 13, 2025 for Q3 2025 where it was disclosed a total value porftolio of $230 Million distributed in 52 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Berkshire Hathaway Inc Class B with a value of $50.7M, Bank Of Nova Scotia with a value of $26.5M, Toronto Dominion Bank with a value of $22.5M, Magna International Inc with a value of $20.9M, and Cigna Corp with a value of $20.8M.

Examining the 13F form we can see an decrease of $14.4M in the current position value, from $244M to 230M.

Portland Investment Counsel Inc. is based out at Burlington, A6

Below you can find more details about Portland Investment Counsel Inc. portfolio as well as his latest detailed transactions.

Portfolio value $230 Million
Financial Services: $118 Million
Healthcare: $58.8 Million
Consumer Cyclical: $25.7 Million
Energy: $6.52 Million
Technology: $6.23 Million
Industrials: $6.03 Million
Communication Services: $4.95 Million
ETFs: $2.92 Million
Other: $1.12 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$662B
$50.7 Million 22.03% of portfolio
100,783
Q2 2025 Reduced 5.33%
$80.2B
$26.5 Million 11.51% of portfolio
409,629
Q4 2024 Reduced 0.82%
$148B
$22.5 Million 9.79% of portfolio
281,700
Q3 2025 Reduced 25.89%
$14.2B
$20.9 Million 9.11% of portfolio
442,068
Q3 2025 Reduced 52.49%
$82.8B
$20.8 Million 9.05% of portfolio
72,200
Q2 2025 Reduced 29.63%
$78.2B
$18.8 Million 8.16% of portfolio
58,100
Q4 2024 New
$24.4B
$14.5 Million 6.3% of portfolio
90,624
Q2 2025 Reduced 5.38%
$160B
$11.8 Million 5.15% of portfolio
59,754
Q2 2025 Added 9.13%
$3.44B
$3.49 Million 1.52% of portfolio
11,250
Q2 2025 Added 12.5%
$4.31B
$3.2 Million 1.39% of portfolio
42,000
Q2 2025 Added 5.0%
$29B
$3.2 Million 1.39% of portfolio
110,702
Q1 2025 Added 22.05%
$0
$2.92 Million 1.27% of portfolio
31,821
Q3 2025 Added 225.07%
$465B
$2.29 Million 1.0% of portfolio
12,271
Q2 2025 Added 76.61%
$36.7B
$2.01 Million 0.87% of portfolio
24,000
Q1 2025 Added 33.33%
$1.65T
$2.01 Million 0.87% of portfolio
8,266
Q2 2024 Reduced 0.84%
$265B
$1.79 Million 0.78% of portfolio
2,251
Q2 2024 Reduced 0.84%
$954M
$1.62 Million 0.7% of portfolio
45,000
Q2 2025 Added 12.5%
$4.3T
$1.56 Million 0.68% of portfolio
6,134
Q2 2025 Added 19.48%
$2.39T
$1.56 Million 0.68% of portfolio
7,120
Q2 2024 Reduced 0.84%
$20B
$1.52 Million 0.66% of portfolio
18,000
Q2 2025 Added 20.0%
$3.78T
$1.37 Million 0.59% of portfolio
2,637
Q2 2025 Added 23.4%
$16.3B
$1.29 Million 0.56% of portfolio
7,000
Q2 2025 Added 7.69%
$111B
$1.12 Million 0.49% of portfolio
3,400
Q2 2025 Added 30.77%
$2.03B
$1.02 Million 0.44% of portfolio
280,300
Q1 2023 New
$881B
$946,000 0.41% of portfolio
3,000
Q2 2025 Reduced 52.01%
$3.64B
$923,000 0.4% of portfolio
18,000
Q3 2025 Added 38.46%
$512B
$775,000 0.34% of portfolio
1,363
Q2 2024 Reduced 0.8%
$68.7B
$760,000 0.33% of portfolio
9,100
Q2 2025 New
$17.1B
$724,000 0.31% of portfolio
2,244
Q4 2024 Added 177.72%
$1.44B
$698,000 0.3% of portfolio
82,703
Q3 2025 Reduced 46.23%
$23.5B
$680,000 0.3% of portfolio
3,000
Q3 2024 Added 50.0%
$971B
$659,000 0.29% of portfolio
865
Q4 2024 New
$362M
$589,000 0.26% of portfolio
71,100
Q3 2025 New
$13.2B
$525,000 0.23% of portfolio
3,000
Q2 2025 Added 50.0%
$237B
$498,000 0.22% of portfolio
2,102
Q3 2025 New
$40.3B
$515,000 0.22% of portfolio
1,526
Q3 2025 New
$351M
$482,000 0.21% of portfolio
50,000
Q1 2025 Added 100.0%
$390M
$282,000 0.12% of portfolio
130,000
Q2 2025 Added 30.0%
$1.09B
$200,000 0.09% of portfolio
10,000
Q2 2025 New
$98.1M
$172,000 0.07% of portfolio
250,000
Q2 2025 Added 31.58%
$192M
$116,000 0.05% of portfolio
15,000
Q1 2025 New
$1.3B
$116,000 0.05% of portfolio
50,000
Q2 2024 Added 66.67%
$562M
$119,000 0.05% of portfolio
14,000
Q1 2025 New
$796M
$52,000 0.02% of portfolio
10,000
Q3 2024 New
Amgen Inc
-
$0 0.0% of portfolio
-
Q2 2024 Added 50.0%
Telix Pharmaceutical LTD
-
$0 0.0% of portfolio
-
Q3 2025 New
South Bow Corp
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 24.42%
Ge Vernova Inc
-
$0 0.0% of portfolio
-
Q3 2025 New
Brookfield Asset Managmt LTD
-
$0 0.0% of portfolio
-
Q2 2025 Added 5.06%

Summary

  • Portfolio
  • No. of Stocks 52
  • Current Value $230 Million
  • Prior Value $244 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 13, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 5 stocks
  • Additional Purchases 2 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 5 stocks
Track This Portfolio

Track Portland Investment Counsel Inc. Portfolio

Follow Portland Investment Counsel Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Portland Investment Counsel Inc., based on Form 13F filings with the SEC.

News

Stay updated on Portland Investment Counsel Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email